1. What is already known about this subject:
- Inconsistent doses of Hydroxychloroquine are included in national
guidelines and clinical studies protocols for management of COVID-19
disease.
- Modelling and simulation approaches have recently been proposed for
dose selection but (external) clinical validation was either lacking or
carrying important limitations and unverified assumptions.